Wednesday, November 21, 2018

Cancer Gene Therapy - Table of Contents alert Volume 25 Issue 11-12

Cancer Gene Therapy

TABLE OF CONTENTS

Volume 25, Issue 11-12

In this issue
Article
Correction
Also new
AOP

Article

Cytotoxic response of 5-fluorouracil-resistant cells to gene- and cell-directed enzyme/prodrug treatment

Erika Durinikova, Jana Plava, Silvia Tyciakova, Pavel Skvara, Andrea Vojs Stanova et al.

Cancer Gene Therapy 2018 25 :285 - 299; June 21, 2018; 10.1038/s41417-018-0030-5

Abstract | Full Text

Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB

Xiao Han, Jing-Jing Zhang, Zheng-Quan Han, Hai-Bin Zhang & Zi-An Wang

Cancer Gene Therapy 2018 25 :300 - 308; September 20, 2018; 10.1038/s41417-018-0048-8

Abstract | Full Text

Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells

Biao Yang, Yan-Bin Ma & Sheng-Hua Chu

Cancer Gene Therapy 2018 25 :309 - 316; August 24, 2018; 10.1038/s41417-018-0040-3

Abstract | Full Text

Upregulation of microRNA-3129 suppresses epithelial ovarian cancer through CD44

Xiaochun Sun, Manhua Cui, Lingling Tong, Aichen Zhang & Kun Wang

Cancer Gene Therapy 2018 25 :317 - 325; June 19, 2018; 10.1038/s41417-018-0026-1

Abstract | Full Text

Inhibition of microRNA-384-5p alleviates osteoarthritis through its effects on inhibiting apoptosis of cartilage cells via the NF-κB signaling pathway by targeting SOX9

Weikai Zhang, Peng Cheng, Weihua Hu, Weifeng Yin, Fengjing Guo et al.

Cancer Gene Therapy 2018 25 :326 - 338; July 30, 2018; 10.1038/s41417-018-0029-y

Abstract | Full Text

Correction

Correction: Increasing the bactofection capacity of a mammalian expression vector by removal of the f1 ori

Síle A. Johnson, Michael J. Ormsby, Anne McIntosh, Stephen W. G. Tait, Karen Blyth et al.

Cancer Gene Therapy 2018 25 :339 - 339; September 19, 2018; 10.1038/s41417-018-0047-9

Abstract | Full Text

Advertisement
Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours.

Click here to sign up.
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription.

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription.

This email has been sent to edgeblog.alerts.2011.001@gmail.com.

If you no longer wish to receive the email alerts from Cancer Gene Therapy click here to unsubscribe .
If you wish to discontinue all email services from Nature Research please click here to unsubscribe .

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Research | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.

Springer Nature
 

No comments: